Records containing: Thyroid Gland Papillary Carcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-27Health and Wellness Coaching to Improve Patient Activation and Adherence to Healthy Habits in Differentiated Thyroid Cancer Care: A Mixed-Methods Pilot Study
-
CLINICAL_TRIALS study record update · 2026-04-22Health and Wellness Coaching to Improve Patient Activation and Adherence to Healthy Habits in Differentiated Thyroid Cancer Care: A Mixed-Methods Pilot Study
-
CLINICAL_TRIALS study record update · 2026-04-14Personalized Cancer Support for Young Adults
-
CLINICAL_TRIALS study record update · 2026-02-27Evaluation of F-18 Tetrafluoroborate (18F-TFB) PET/CT in Patients With Differentiated Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2026-02-02A Pilot Clinical Trial of Vemurafenib and Cobimetinib as a Redifferentiation Strategy in High-Risk, Radioactive Iodine (RAI) Naïve, BRAFV600E Mutated Differentiated Thyroid Carcinoma Patients Undergoing Initial RAI Therapy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-11-13Neoadjuvant Treatment With Selpercatinib in RET-Altered Thyroid Cancers
-
CLINICAL_TRIALS study record update · 2025-10-31Phase II Study of XL184 (Cabozantinib) in Combination With Nivolumab and Ipilimumab (CaboNivoIpi) in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer Whose Cancer Progressed After One Prior VEGFR-Targeted Therapy
-
CLINICAL_TRIALS study record update · 2025-04-02Radiofrequency Ablation Use in Thyroid Nodule
-
CLINICAL_TRIALS study record update · 2022-11-10A Phase 2 Study of Lenvatinib in Combination With Radioactive Iodine Therapy in Patients With Progressive RAI-Sensitive Differentiated Thyroid Cancer